BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 34369265)

  • 21. TP53 mutation is related to poor prognosis after radiotherapy, but not surgery, in squamous cell carcinoma of the head and neck.
    Alsner J; Sørensen SB; Overgaard J
    Radiother Oncol; 2001 May; 59(2):179-85. PubMed ID: 11325447
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence and Risk Factors of Distant Metastases of Head and Neck Carcinoma.
    Uhliarová B; Švec M
    Klin Onkol; 2019; 32(4):294-299. PubMed ID: 31426646
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical, ultrasound and histopathological correlation of clinically N0 neck nodes in patients with cancers of the pharynx and larynx.
    Iovănescu G; Bîrsăşteanu F; Borugă VM; Apostol A; Ştefănescu EH; Budu VA; Baderca F; Trifu SC; Mogoantă CA; Bonţe DC; Ivan MV
    Rom J Morphol Embryol; 2020; 61(2):433-439. PubMed ID: 33544794
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Larynx-sparing radiotherapy for squamous cell carcinoma from an unknown head and neck primary site.
    Barker CA; Morris CG; Mendenhall WM
    Am J Clin Oncol; 2005 Oct; 28(5):445-8. PubMed ID: 16199981
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sebaceous Differentiation in Squamous Cell Carcinoma of the Larynx and Adjacent Pharynx: Case Report with Review and Discussion of the Literature.
    Cardesa A; Nadal A; Alos L; Lloreta-Trull J; Ferlito A
    Head Neck Pathol; 2018 Mar; 12(1):118-122. PubMed ID: 28721661
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Feasibility of Salvage Selective Neck Dissection after Primary Irradiation of Pharyngeal and Laryngeal Carcinoma.
    Mat Lazim N; Abdullah K; Karakullukcu B; Tan IB
    ORL J Otorhinolaryngol Relat Spec; 2018; 80(1):10-18. PubMed ID: 29428959
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence and distribution of cervical lymph node metastases in HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma.
    Bauwens L; Baltres A; Fiani DJ; Zrounba P; Buiret G; Fleury B; Benzerdjeb N; Grégoire V
    Radiother Oncol; 2021 Apr; 157():122-129. PubMed ID: 33545255
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distant metastases in terminal head and neck cancer patients.
    Talmi YP; Cotlear D; Waller A; Horowitz Z; Adunski A; Roth Y; Kronenberg J
    J Laryngol Otol; 1997 May; 111(5):454-8. PubMed ID: 9205608
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DAHANCA 28: A phase I/II feasibility study of hyperfractionated, accelerated radiotherapy with concomitant cisplatin and nimorazole (HART-CN) for patients with locally advanced, HPV/p16-negative squamous cell carcinoma of the oropharynx, hypopharynx, larynx and oral cavity.
    Saksø M; Jensen K; Andersen M; Hansen CR; Eriksen JG; Overgaard J
    Radiother Oncol; 2020 Jul; 148():65-72. PubMed ID: 32335364
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regional metastases in patients with advanced laryngeal cancer. Department of Veterans Affairs Laryngeal Cancer Study Group.
    Moe K; Wolf GT; Fisher SG; Hong WK
    Arch Otolaryngol Head Neck Surg; 1996 Jun; 122(6):644-8. PubMed ID: 8639297
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prognostic factors affecting results of comprehensive treatment of hypopharyngeal carcinoma].
    Xu W; Lyu Z; Yang Z; Zou J; Cao H
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Jul; 49(7):533-8. PubMed ID: 25257265
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of p-16 Positive Laryngeal and Pharyngeal Tumors in Nepalese Population: A Hospital based Cross-sectional Study.
    Gyawali BR; Acharya K; Sapkota R; Baskota DK; Sinha BK
    JNMA J Nepal Med Assoc; 2020 Sep; 58(229):681-685. PubMed ID: 33068091
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical features of human papilloma virus-related head and neck squamous cell carcinoma of an unknown primary site.
    Kobayashi K; Saito Y; Omura G; Ando M; Sakamoto T; Yamasoba T; Asakage T
    ORL J Otorhinolaryngol Relat Spec; 2014; 76(3):137-46. PubMed ID: 24993345
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distant metastases from head and neck squamous cell carcinomas.
    Calhoun KH; Fulmer P; Weiss R; Hokanson JA
    Laryngoscope; 1994 Oct; 104(10):1199-205. PubMed ID: 7934588
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patterns of Treatment Failure and Postrecurrence Outcomes Among Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma After Chemoradiotherapy Using Modern Radiation Techniques.
    Leeman JE; Li JG; Pei X; Venigalla P; Zumsteg ZS; Katsoulakis E; Lupovitch E; McBride SM; Tsai CJ; Boyle JO; Roman BR; Morris LGT; Dunn LA; Sherman EJ; Lee NY; Riaz N
    JAMA Oncol; 2017 Nov; 3(11):1487-1494. PubMed ID: 28542679
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The use of an immunohistochemical diagnostic panel to determine the primary site of cervical lymph node metastases of occult squamous cell carcinoma.
    Park JM; Jung CK; Choi YJ; Lee KY; Kang JH; Kim MS; Hu HJ
    Hum Pathol; 2010 Mar; 41(3):431-7. PubMed ID: 19954817
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Double positivity for HPV DNA/p16 in tonsillar and base of tongue cancer improves prognostication: Insights from a large population-based study.
    Garnaes E; Frederiksen K; Kiss K; Andersen L; Therkildsen MH; Franzmann MB; Specht L; Andersen E; Norrild B; Kjaer SK; von Buchwald C
    Int J Cancer; 2016 Dec; 139(11):2598-605. PubMed ID: 27537425
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HPV-associated neuroendocrine carcinomas of the head and neck in FNA biopsies: Clinicopathologic features of a rare entity.
    Jo VY; Krane JF; Pantanowitz L; Monaco SE
    Cancer Cytopathol; 2019 Feb; 127(1):26-34. PubMed ID: 30475447
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Robust Differences in p16-Dependent Oropharyngeal Squamous Cell Carcinoma Distant Metastasis: Implications for Targeted Therapy.
    Jaber JJ; Murrill L; Clark JI; Johnson JT; Feustel PJ; Mehta V
    Otolaryngol Head Neck Surg; 2015 Aug; 153(2):209-17. PubMed ID: 25917669
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pretreatment screening on distant metastases and head and neck cancer patients: Validation of risk factors and influence on survival.
    Peters TT; Senft A; Hoekstra OS; Castelijns JA; Witte BI; Leemans CR; de Bree R
    Oral Oncol; 2015 Mar; 51(3):267-71. PubMed ID: 25552384
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.